Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-018206
Filing Date
2020-04-23
Accepted
2020-04-23 16:20:30
Documents
39
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20200331.htm 10-Q 793731
2 EX-31.1 mnov-ex311_8.htm EX-31.1 11235
3 EX-31.2 mnov-ex312_106.htm EX-31.2 11265
4 EX-32.1 mnov-ex321_9.htm EX-32.1 8012
5 EX-32.2 mnov-ex322_107.htm EX-32.2 8046
  Complete submission text file 0001564590-20-018206.txt   2345110

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20200331.xml EX-101.INS 290566
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20200331.xsd EX-101.SCH 23191
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20200331_cal.xml EX-101.CAL 22240
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20200331_def.xml EX-101.DEF 62895
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20200331_lab.xml EX-101.LAB 206357
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20200331_pre.xml EX-101.PRE 148108
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 20811254
SIC: 2834 Pharmaceutical Preparations